Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Asylia Diagnostics
Asylia Diagnostics, founded in 2019, is a precision medicine platform focused on immunotherapies. They collect multi-modal data, including molecular, chemical, and real-world evidence (RWE) from…
Asylia Diagnostics
Asylia Diagnostics, founded in 2019, is a precision medicine platform focused on immunotherapies. They collect multi-modal data, including molecular, chemical, and real-world evidence (RWE) from…
TL;DR
Founded: 2019
Focus: Precision medicine for immunotherapies (oncology, autoimmune)
Proprietary tech: AsyliaAI generative-AI platform
Initial clinical product: Molecular test for metastatic melanoma (PD-1 treated patients)
Reported funding: $1.1M seed (reported) / grant support noted
Company Overview
Problem Domain
Biomarker discovery, patient stratification, theranostics for immunotherapies (oncology and autoimmune indications).
Founded
2019
Industry
Biotechnology
Funding Track Record
$1,100,000
Reported by Crunchbase
Investor Signal
“BlueHealth Innovation Center; imec; Davidovs Venture Collective; participation/support from EIT Health”